474 related articles for article (PubMed ID: 27754483)
1. Association between polygenic risk for schizophrenia, neurocognition and social cognition across development.
Germine L; Robinson EB; Smoller JW; Calkins ME; Moore TM; Hakonarson H; Daly MJ; Lee PH; Holmes AJ; Buckner RL; Gur RC; Gur RE
Transl Psychiatry; 2016 Oct; 6(10):e924. PubMed ID: 27754483
[TBL] [Abstract][Full Text] [Related]
2. Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia.
Wang SH; Hsiao PC; Yeh LL; Liu CM; Liu CC; Hwang TJ; Hsieh MH; Chien YL; Lin YT; Chandler SD; Faraone SV; Laird N; Neale B; McCarroll SA; Glatt SJ; Tsuang MT; Hwu HG; Chen WJ
Genes Brain Behav; 2018 Jan; 17(1):49-55. PubMed ID: 28719030
[TBL] [Abstract][Full Text] [Related]
3. Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.
Toulopoulou T; Zhang X; Cherny S; Dickinson D; Berman KF; Straub RE; Sham P; Weinberger DR
Brain; 2019 Feb; 142(2):471-485. PubMed ID: 30535067
[TBL] [Abstract][Full Text] [Related]
4. Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomains.
Erk S; Mohnke S; Ripke S; Lett TA; Veer IM; Wackerhagen C; Grimm O; Romanczuk-Seiferth N; Degenhardt F; Tost H; Mattheisen M; Mühleisen TW; Charlet K; Skarabis N; Kiefer F; Cichon S; Witt SH; Nöthen MM; Rietschel M; Heinz A; Meyer-Lindenberg A; Walter H
Transl Psychiatry; 2017 Jan; 7(1):e997. PubMed ID: 28072415
[TBL] [Abstract][Full Text] [Related]
5. Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population.
Musliner KL; Mortensen PB; McGrath JJ; Suppli NP; Hougaard DM; Bybjerg-Grauholm J; Bækvad-Hansen M; Andreassen O; Pedersen CB; Pedersen MG; Mors O; Nordentoft M; Børglum AD; Werge T; Agerbo E;
JAMA Psychiatry; 2019 May; 76(5):516-525. PubMed ID: 30698613
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive growth charting in psychosis spectrum youths.
Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
[TBL] [Abstract][Full Text] [Related]
7. Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.
Voineskos AN; Felsky D; Wheeler AL; Rotenberg DJ; Levesque M; Patel S; Szeszko PR; Kennedy JL; Lencz T; Malhotra AK
Schizophr Bull; 2016 Jul; 42(4):1027-36. PubMed ID: 26712857
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.
Rose EJ; Hargreaves A; Morris D; Fahey C; Tropea D; Cummings E; Caltagirone C; Bossù P; Chiapponi C; Piras F; Spalletta G; Gill M; Corvin A; Donohoe G
Br J Psychiatry; 2014 Feb; 204(2):115-21. PubMed ID: 24311551
[TBL] [Abstract][Full Text] [Related]
9. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
Pardiñas AF; Smart SE; Willcocks IR; Holmans PA; Dennison CA; Lynham AJ; Legge SE; Baune BT; Bigdeli TB; Cairns MJ; Corvin A; Fanous AH; Frank J; Kelly B; McQuillin A; Melle I; Mortensen PB; Mowry BJ; Pato CN; Periyasamy S; Rietschel M; Rujescu D; Simonsen C; St Clair D; Tooney P; Wu JQ; Andreassen OA; Kowalec K; Sullivan PF; Murray RM; Owen MJ; MacCabe JH; O'Donovan MC; Walters JTR; ; Ajnakina O; Alameda L; Barnes TRE; Berardi D; Bonora E; Camporesi S; Cleusix M; Conus P; Crespo-Facorro B; D'Andrea G; Demjaha A; Do KQ; Doody GA; Eap CB; Ferchiou A; Di Forti M; Guidi L; Homman L; Jenni R; Joyce EM; Kassoumeri L; Khadimallah I; Lastrina O; Muratori R; Noyan H; O'Neill FA; Pignon B; Restellini R; Richard JR; Schürhoff F; Španiel F; Szöke A; Tarricone I; Tortelli A; Üçok A; Vázquez-Bourgon J
JAMA Psychiatry; 2022 Mar; 79(3):260-269. PubMed ID: 35019943
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.
Shafee R; Nanda P; Padmanabhan JL; Tandon N; Alliey-Rodriguez N; Kalapurakkel S; Weiner DJ; Gur RE; Keefe RSE; Hill SK; Bishop JR; Clementz BA; Tamminga CA; Gershon ES; Pearlson GD; Keshavan MS; Sweeney JA; McCarroll SA; Robinson EB
Transl Psychiatry; 2018 Apr; 8(1):78. PubMed ID: 29643358
[TBL] [Abstract][Full Text] [Related]
11. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood.
Hatzimanolis A; Bhatnagar P; Moes A; Wang R; Roussos P; Bitsios P; Stefanis CN; Pulver AE; Arking DE; Smyrnis N; Stefanis NC; Avramopoulos D
Am J Med Genet B Neuropsychiatr Genet; 2015 Jul; 168B(5):392-401. PubMed ID: 25963331
[TBL] [Abstract][Full Text] [Related]
13. Association between schizophrenia polygenic risk and neural correlates of emotion perception.
Dzafic I; Burianová H; Periyasamy S; Mowry B
Psychiatry Res Neuroimaging; 2018 Jun; 276():33-40. PubMed ID: 29723776
[TBL] [Abstract][Full Text] [Related]
14. Short communication: Genetic association between schizophrenia and cannabis use.
Verweij KJ; Abdellaoui A; Nivard MG; Sainz Cort A; Ligthart L; Draisma HH; Minică CC; ; Gillespie NA; Willemsen G; Hottenga JJ; Boomsma DI; Vink JM
Drug Alcohol Depend; 2017 Feb; 171():117-121. PubMed ID: 28086176
[TBL] [Abstract][Full Text] [Related]
15. Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia.
Hartz SM; Horton AC; Oehlert M; Carey CE; Agrawal A; Bogdan R; Chen LS; Hancock DB; Johnson EO; Pato CN; Pato MT; Rice JP; Bierut LJ
Biol Psychiatry; 2017 Nov; 82(10):709-715. PubMed ID: 28739213
[TBL] [Abstract][Full Text] [Related]
16. Effects of autozygosity and schizophrenia polygenic risk on cognitive and brain developmental trajectories.
Córdova-Palomera A; Kaufmann T; Bettella F; Wang Y; Doan NT; van der Meer D; Alnæs D; Rokicki J; Moberget T; Sønderby IE; Andreassen OA; Westlye LT
Eur J Hum Genet; 2018 Jul; 26(7):1049-1059. PubMed ID: 29700391
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
Jabben N; Arts B; van Os J; Krabbendam L
J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
[TBL] [Abstract][Full Text] [Related]
18. The neuropsychology of schizophrenia: a neurodevelopmental and case study approach.
Seidman LJ
J Neuropsychiatry Clin Neurosci; 1990; 2(3):301-12. PubMed ID: 2136090
[No Abstract] [Full Text] [Related]
19. Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.
Nakahara S; Medland S; Turner JA; Calhoun VD; Lim KO; Mueller BA; Bustillo JR; O'Leary DS; Vaidya JG; McEwen S; Voyvodic J; Belger A; Mathalon DH; Ford JM; Guffanti G; Macciardi F; Potkin SG; van Erp TGM
Schizophr Res; 2018 Nov; 201():393-399. PubMed ID: 29907492
[TBL] [Abstract][Full Text] [Related]
20. Polygenic risk for schizophrenia and associated brain structural changes: A systematic review.
van der Merwe C; Passchier R; Mufford M; Ramesar R; Dalvie S; Stein DJ
Compr Psychiatry; 2019 Jan; 88():77-82. PubMed ID: 30529765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
